Incidence and Economic Burden of Infections in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort Study

Abstract excerpt

<title>Abstract</title> <p>BACKGROUNDAlong with antitumor effects, Immune Checkpoint Inhibitors (ICPI) have shown great potential in treating chronic infections such as HIV, Hepatitis B and malaria, in ex-vivo studies. However, several case reports and case series have suggested an increased infection risk in cancer patients. The purpose of our study was to assess the risk of infections in cancer patients receivi...

Topics

Open a Topic to create a Post that cites this publication.

• Hematopoietic Stem Cell Transplantation
• HIV Infections
• Immunocompromised Host
• Infections
• Mutation
• Neoplasms
• Organ Transplantation
• Risk Factors

Identifiers and source

Literature Corpus work

9ffa2730-d1ac-5e21-ad80-712e861b70ae

DOI

10.21203/rs.3.rs-64420/v1